JP2024544597A - がん分類のための汚染片のサンプル汚染検出 - Google Patents

がん分類のための汚染片のサンプル汚染検出 Download PDF

Info

Publication number
JP2024544597A
JP2024544597A JP2024530567A JP2024530567A JP2024544597A JP 2024544597 A JP2024544597 A JP 2024544597A JP 2024530567 A JP2024530567 A JP 2024530567A JP 2024530567 A JP2024530567 A JP 2024530567A JP 2024544597 A JP2024544597 A JP 2024544597A
Authority
JP
Japan
Prior art keywords
cancer
contamination
markers
fragments
sites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024530567A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024544597A5 (https=
Inventor
エス グロス サミュエル
バガリア シッダールタ
Original Assignee
グレイル インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by グレイル インコーポレイテッド filed Critical グレイル インコーポレイテッド
Publication of JP2024544597A publication Critical patent/JP2024544597A/ja
Publication of JP2024544597A5 publication Critical patent/JP2024544597A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/10—Characterised by chemical treatment
    • C12Q2523/125—Bisulfite(s)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/164—Methylation detection other then bisulfite or methylation sensitive restriction endonucleases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7023—(Hyper)proliferation
    • G01N2800/7028—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Data Mining & Analysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Primary Health Care (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Theoretical Computer Science (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Evolutionary Biology (AREA)
  • Bioethics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Artificial Intelligence (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2024530567A 2021-11-23 2022-11-23 がん分類のための汚染片のサンプル汚染検出 Pending JP2024544597A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163282509P 2021-11-23 2021-11-23
US63/282,509 2021-11-23
PCT/US2022/080431 WO2023097278A1 (en) 2021-11-23 2022-11-23 Sample contamination detection of contaminated fragments for cancer classification

Publications (2)

Publication Number Publication Date
JP2024544597A true JP2024544597A (ja) 2024-12-03
JP2024544597A5 JP2024544597A5 (https=) 2025-11-10

Family

ID=84830091

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024530567A Pending JP2024544597A (ja) 2021-11-23 2022-11-23 がん分類のための汚染片のサンプル汚染検出

Country Status (10)

Country Link
US (1) US20230272477A1 (https=)
EP (1) EP4437130A1 (https=)
JP (1) JP2024544597A (https=)
KR (1) KR20240103061A (https=)
CN (1) CN118591638A (https=)
AU (1) AU2022398491A1 (https=)
CA (1) CA3237953A1 (https=)
IL (1) IL312808A (https=)
TW (1) TW202330933A (https=)
WO (1) WO2023097278A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019234843B2 (en) * 2018-03-13 2025-12-04 Grail, Inc. Anomalous fragment detection and classification
EP4177356B1 (en) * 2018-08-08 2024-05-08 PML Screening, LLC Methods for assessing risk of developing a viral disease using a genetic test
US12234514B2 (en) * 2018-12-21 2025-02-25 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free DNA samples
WO2020232109A1 (en) * 2019-05-13 2020-11-19 Grail, Inc. Model-based featurization and classification
US20210310075A1 (en) * 2020-03-30 2021-10-07 Grail, Inc. Cancer Classification with Synthetic Training Samples
AU2021248552A1 (en) * 2020-03-31 2022-11-03 Grail, Llc Cancer classification with genomic region modeling
JP2024538725A (ja) * 2021-10-08 2024-10-23 ファウンデーション・メディシン・インコーポレイテッド コピー数変化呼び出しに対する汚染を検出及び除去するための方法及びシステム

Also Published As

Publication number Publication date
TW202330933A (zh) 2023-08-01
CN118591638A (zh) 2024-09-03
AU2022398491A1 (en) 2024-06-06
KR20240103061A (ko) 2024-07-03
WO2023097278A1 (en) 2023-06-01
US20230272477A1 (en) 2023-08-31
CA3237953A1 (en) 2023-06-01
EP4437130A1 (en) 2024-10-02
IL312808A (en) 2024-07-01

Similar Documents

Publication Publication Date Title
JP7498793B2 (ja) 合成トレーニングサンプルによるがん分類
US20240170099A1 (en) Methylation-based age prediction as feature for cancer classification
US20240412821A1 (en) Methylation-based biological sex prediction
US20240055073A1 (en) Sample contamination detection of contaminated fragments with cpg-snp contamination markers
US20240021267A1 (en) Dynamically selecting sequencing subregions for cancer classification
KR20250154498A (ko) 백혈구 오염 검출
US20230272477A1 (en) Sample contamination detection of contaminated fragments for cancer classification
US20240309461A1 (en) Sample barcode in multiplex sample sequencing
US20240233872A9 (en) Component mixture model for tissue identification in dna samples
US20240296920A1 (en) Redacting cell-free dna from test samples for classification by a mixture model
WO2026015665A1 (en) Determining methylation status of biological samples

Legal Events

Date Code Title Description
A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20240805

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251029

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251029